Contineum Therapeutics (CTNM) Other Gross PP&E Adjustments: 2023-2025
Historic Other Gross PP&E Adjustments for Contineum Therapeutics (CTNM) over the last 2 years, with Sep 2025 value amounting to -$4.8 million.
- Contineum Therapeutics' Other Gross PP&E Adjustments fell 2354.82% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 million, marking a year-over-year decrease of 572.88%. This contributed to the annual value of -$2.9 million for FY2024, which is 574.92% down from last year.
- Latest data reveals that Contineum Therapeutics reported Other Gross PP&E Adjustments of -$4.8 million as of Q3 2025, which was up 6.80% from -$5.2 million recorded in Q2 2025.
- Over the past 5 years, Contineum Therapeutics' Other Gross PP&E Adjustments peaked at $602,000 during Q4 2023, and registered a low of -$5.4 million during Q1 2025.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$2.8 million (2024), whereas its average is -$2.6 million.
- Data for Contineum Therapeutics' Other Gross PP&E Adjustments shows a maximum YoY crashed of 2,354.82% (in 2025) over the last 5 years.
- Contineum Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $602,000 in 2023, then plummeted by 574.92% to -$2.9 million in 2024, then plummeted by 2,354.82% to -$4.8 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$4.8 million for Q3 2025, versus -$5.2 million for Q2 2025 and -$5.4 million for Q1 2025.